Karyopharm Therapeut (KPTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 30,542 | 38,783 | 42,786 | 33,126 | 33,747 |
| Cost of Goods | 1,331 | 1,300 | 1,465 | 1,911 | 1,486 |
| Gross Profit | 29,211 | 37,483 | 41,321 | 31,215 | 32,261 |
| Operating Expenses | 60,823 | 64,066 | 69,906 | 65,885 | 70,555 |
| Operating Income | -31,281 | -26,283 | -28,120 | -33,759 | -37,808 |
| Interest Expense | 11,204 | 11,385 | 8,949 | 5,884 | 6,208 |
| Other Income | 11,596 | 5,624 | 60,928 | 2,352 | 2,309 |
| Pre-tax Income | -30,889 | -32,044 | 23,859 | -37,291 | -41,707 |
| Income Tax | -109 | 28 | 67 | 71 | 130 |
| Net Income Continuous | -30,780 | -32,072 | 23,792 | -37,362 | -41,837 |
| Net Income | $-30,780 | $-32,072 | $23,792 | $-37,362 | $-41,837 |
| EPS Basic Total Ops | -2.97 | -3.85 | 2.26 | -4.85 | -5.45 |
| EPS Basic Continuous Ops | -3.65 | -3.85 | 2.95 | -4.85 | -5.48 |
| EPS Diluted Total Ops | -2.33 | -3.85 | -2.97 | -4.85 | -5.45 |
| EPS Diluted Continuous Ops | -2.65 | -3.85 | 2.31 | -4.85 | -5.48 |
| EPS Diluted Before Non-Recurring Items | -3.60 | -3.90 | -3.00 | N/A | N/A |
| EBITDA(a) | $-29,235 | $-24,324 | $-27,302 | $-34,377 | $-38,535 |